For example, a study from our group and collaborators demonstrated that Tregs from T1D patients can exhibit reduced responsiveness to IL-2 leading to reduced Treg frequency, loss of FoxP3 expression, and reduced suppressive function [68]. Here, IL2 is linked to type 1 diabetes mellitus.